- Home
- PRAX vs RWT Comparison
PRAX vs RWT Comparison
Compare PRAX & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- RWT
- Stock Information
- Founded
- PRAX 2015
- RWT 1994
- Country
- PRAX United States
- RWT United States
- Employees
- PRAX N/A
- RWT N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- RWT Real Estate Investment Trusts
- Sector
- PRAX Health Care
- RWT Real Estate
- Exchange
- PRAX Nasdaq
- RWT Nasdaq
- Market Cap
- PRAX 599.7M
- RWT 678.2M
- IPO Year
- PRAX 2020
- RWT 1995
- Fundamental
- Price
- PRAX $38.35
- RWT $5.84
- Analyst Decision
- PRAX Strong Buy
- RWT Buy
- Analyst Count
- PRAX 10
- RWT 11
- Target Price
- PRAX $116.50
- RWT $7.59
- AVG Volume (30 Days)
- PRAX 430.8K
- RWT 1.1M
- Earning Date
- PRAX 05-02-2025
- RWT 04-30-2025
- Dividend Yield
- PRAX N/A
- RWT 11.84%
- EPS Growth
- PRAX N/A
- RWT 105.35
- EPS
- PRAX N/A
- RWT 0.21
- Revenue
- PRAX $8,122,000.00
- RWT $241,948,000.00
- Revenue This Year
- PRAX N/A
- RWT N/A
- Revenue Next Year
- PRAX $789.73
- RWT $12.23
- P/E Ratio
- PRAX N/A
- RWT $27.64
- Revenue Growth
- PRAX 270.02
- RWT 29.94
- 52 Week Low
- PRAX $26.70
- RWT $4.68
- 52 Week High
- PRAX $91.83
- RWT $8.15
- Technical
- Relative Strength Index (RSI)
- PRAX 53.31
- RWT 49.42
- Support Level
- PRAX $34.89
- RWT $5.83
- Resistance Level
- PRAX $40.89
- RWT $5.98
- Average True Range (ATR)
- PRAX 2.30
- RWT 0.18
- MACD
- PRAX 0.70
- RWT 0.01
- Stochastic Oscillator
- PRAX 57.95
- RWT 39.58
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.